Misplaced Pages

This is an old revision of this page, as edited by SV Resolution (talk | contribs) at 15:29, 30 April 2009 (allegations of COI in critiques of Soffritti studies). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Here are some tasks awaiting attention: Cleanup : Scientific publications -- weak Gone --SV Resolution(Talk) 15:29, 30 April 2009 (UTC) Alleged conflict of intrerest prior to 1996 -- should this be merged into discussion of approval? Expand : Why the US approval process caused controversy Charges of COI in DOJ handling of FDA's Fraud allegations against Searle. Charges of COI in hirings of 6 FDA personnel (described in GAO 86 report to Metzenbaum) Studies by Olney and others dismissed. Charges of COI when new FDA commissioner overturned unanimous decision of PBOI Senator Metzenbaum's role in returning the controversy to the news. Why the Ramazzinni studies contribute to the controversy Allegations of COI in industry-funded critiques of Soffritti studies ... NPOV : Remember that some parts of this article follow WP:MEDRS and must reflect the preponderance of medical opinion, while other parts of this article follow WP:CONTROVERSY and must explain the controversy. Verify : Different types of sources are appropriate to different sections of this article.